HEADER TOXIN 12-FEB-19 6QNS TITLE CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B TITLE 2 MUTANT I1248W/V1249W IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 AND GD1A TITLE 3 RECEPTORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: BOTULINUM NEUROTOXIN TYPE B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BONT/B,BONTOXILYSIN-B; COMPND 5 EC: 3.4.24.69; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: THE N- AND C-TERMINI WERE NOT VISIBLE. PLEASE KEEP COMPND 9 SEQUENCE NUMBERING OF THE FULL BOTULINUM TOXIN, AS PER THE UPLOADED COMPND 10 PDB, SO THAT IT STARTS AT N862 AND TERMINATES AT E1291. THANK YOU.; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: SYNAPTOTAGMIN-1; COMPND 13 CHAIN: S; COMPND 14 SYNONYM: SYNAPTOTAGMIN I,SYTI,P65; COMPND 15 ENGINEERED: YES; COMPND 16 OTHER_DETAILS: SYNTHETIC PEPTIDE CORRESPONDING TO HUMAN SYNAPTOTAGMIN COMPND 17 1 RESIDUES 33-53 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM; SOURCE 3 ORGANISM_TAXID: 1491; SOURCE 4 GENE: BOTB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS BOTULINUM TOXIN, TOXIN EXPDTA X-RAY DIFFRACTION AUTHOR G.MASUYER,L.YIN,S.ZHANG,S.I.MIYASHITA,M.DONG,P.STENMARK REVDAT 4 24-JAN-24 6QNS 1 HETSYN LINK REVDAT 3 29-JUL-20 6QNS 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 25-MAR-20 6QNS 1 JRNL REVDAT 1 26-FEB-20 6QNS 0 JRNL AUTH L.YIN,G.MASUYER,S.ZHANG,J.ZHANG,S.I.MIYASHITA,D.BURGIN, JRNL AUTH 2 L.LOVELOCK,S.F.COKER,T.M.FU,P.STENMARK,M.DONG JRNL TITL CHARACTERIZATION OF A MEMBRANE BINDING LOOP LEADS TO JRNL TITL 2 ENGINEERING BOTULINUM NEUROTOXIN B WITH IMPROVED THERAPEUTIC JRNL TITL 3 EFFICACY. JRNL REF PLOS BIOL. V. 18 00618 2020 JRNL REFN ESSN 1545-7885 JRNL PMID 32182233 JRNL DOI 10.1371/JOURNAL.PBIO.3000618 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 74.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 22656 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1203 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1620 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.20 REMARK 3 BIN R VALUE (WORKING SET) : 0.3580 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.3780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3813 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.38000 REMARK 3 B22 (A**2) : 2.92000 REMARK 3 B33 (A**2) : -7.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.375 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.234 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.206 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.277 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4000 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3559 ; 0.001 ; 0.018 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5401 ; 1.543 ; 1.665 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8305 ; 1.201 ; 1.599 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 444 ; 9.921 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 239 ;31.455 ;23.598 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 724 ;12.935 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;14.004 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 524 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4362 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 885 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1782 ; 3.759 ; 5.869 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1781 ; 3.755 ; 5.868 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2224 ; 6.103 ; 8.800 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2225 ; 6.102 ; 8.801 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2218 ; 4.031 ; 6.408 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2219 ; 4.031 ; 6.412 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3178 ; 6.676 ; 9.431 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4376 ; 9.495 ;64.913 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4373 ; 9.497 ;64.930 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 862 A 1291 REMARK 3 ORIGIN FOR THE GROUP (A): -10.3473 10.9489 -13.6855 REMARK 3 T TENSOR REMARK 3 T11: 0.0526 T22: 0.1158 REMARK 3 T33: 0.0124 T12: 0.0250 REMARK 3 T13: -0.0079 T23: -0.0232 REMARK 3 L TENSOR REMARK 3 L11: 0.0658 L22: 0.5693 REMARK 3 L33: 0.7659 L12: 0.1902 REMARK 3 L13: -0.0694 L23: -0.1654 REMARK 3 S TENSOR REMARK 3 S11: -0.0183 S12: 0.0108 S13: 0.0169 REMARK 3 S21: -0.0445 S22: -0.0166 S23: 0.0582 REMARK 3 S31: 0.0748 S32: -0.1050 S33: 0.0349 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : S 37 S 52 REMARK 3 ORIGIN FOR THE GROUP (A): 1.7172 42.8483 -31.2027 REMARK 3 T TENSOR REMARK 3 T11: 0.2049 T22: 0.1262 REMARK 3 T33: 0.1042 T12: 0.0573 REMARK 3 T13: -0.0078 T23: 0.1038 REMARK 3 L TENSOR REMARK 3 L11: 1.7779 L22: 6.6615 REMARK 3 L33: 7.0466 L12: 2.4197 REMARK 3 L13: -0.8849 L23: 3.4691 REMARK 3 S TENSOR REMARK 3 S11: -0.0739 S12: -0.0529 S13: 0.0219 REMARK 3 S21: -0.3334 S22: -0.0466 S23: 0.0294 REMARK 3 S31: -0.1705 S32: 0.1463 S33: 0.1205 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6QNS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-FEB-19. REMARK 100 THE DEPOSITION ID IS D_1292100558. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23939 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 74.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.40 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.50 REMARK 200 R MERGE FOR SHELL (I) : 1.46900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4KBB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% V/V PEG6000, 0.1 M MES PH 6.0, 0.2 REMARK 280 M SODIUM CHLORIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 294.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.17200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.55150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.24550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.55150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.17200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.24550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, S, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 850 REMARK 465 SER A 851 REMARK 465 HIS A 852 REMARK 465 MET A 853 REMARK 465 ALA A 854 REMARK 465 SER A 855 REMARK 465 MET A 856 REMARK 465 ASN A 857 REMARK 465 SER A 858 REMARK 465 GLU A 859 REMARK 465 ILE A 860 REMARK 465 LEU A 861 REMARK 465 GLY S 33 REMARK 465 GLU S 34 REMARK 465 GLY S 35 REMARK 465 LYS S 36 REMARK 465 LYS S 53 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 1203 NZ LYS S 44 2.09 REMARK 500 O3 GAL B 4 O6 SIA B 5 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 871 118.46 -166.23 REMARK 500 THR A 902 -169.86 -113.78 REMARK 500 GLU A1023 -34.79 -142.57 REMARK 500 TYR A1140 59.52 -93.60 REMARK 500 TYR A1185 71.48 -111.97 REMARK 500 LYS A1188 170.09 -55.36 REMARK 500 TRP A1249 -70.69 -64.84 REMARK 500 ASP S 38 32.20 -82.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 1270 PRO A 1271 42.08 REMARK 500 REMARK 500 REMARK: NULL DBREF 6QNS A 857 1291 UNP P10844 BXB_CLOBO 857 1291 DBREF 6QNS S 33 53 UNP P21579 SYT1_HUMAN 33 53 SEQADV 6QNS GLY A 850 UNP P10844 EXPRESSION TAG SEQADV 6QNS SER A 851 UNP P10844 EXPRESSION TAG SEQADV 6QNS HIS A 852 UNP P10844 EXPRESSION TAG SEQADV 6QNS MET A 853 UNP P10844 EXPRESSION TAG SEQADV 6QNS ALA A 854 UNP P10844 EXPRESSION TAG SEQADV 6QNS SER A 855 UNP P10844 EXPRESSION TAG SEQADV 6QNS MET A 856 UNP P10844 EXPRESSION TAG SEQADV 6QNS TRP A 1248 UNP P10844 ILE 1248 ENGINEERED MUTATION SEQADV 6QNS TRP A 1249 UNP P10844 VAL 1249 ENGINEERED MUTATION SEQRES 1 A 442 GLY SER HIS MET ALA SER MET ASN SER GLU ILE LEU ASN SEQRES 2 A 442 ASN ILE ILE LEU ASN LEU ARG TYR LYS ASP ASN ASN LEU SEQRES 3 A 442 ILE ASP LEU SER GLY TYR GLY ALA LYS VAL GLU VAL TYR SEQRES 4 A 442 ASP GLY VAL GLU LEU ASN ASP LYS ASN GLN PHE LYS LEU SEQRES 5 A 442 THR SER SER ALA ASN SER LYS ILE ARG VAL THR GLN ASN SEQRES 6 A 442 GLN ASN ILE ILE PHE ASN SER VAL PHE LEU ASP PHE SER SEQRES 7 A 442 VAL SER PHE TRP ILE ARG ILE PRO LYS TYR LYS ASN ASP SEQRES 8 A 442 GLY ILE GLN ASN TYR ILE HIS ASN GLU TYR THR ILE ILE SEQRES 9 A 442 ASN CYS MET LYS ASN ASN SER GLY TRP LYS ILE SER ILE SEQRES 10 A 442 ARG GLY ASN ARG ILE ILE TRP THR LEU ILE ASP ILE ASN SEQRES 11 A 442 GLY LYS THR LYS SER VAL PHE PHE GLU TYR ASN ILE ARG SEQRES 12 A 442 GLU ASP ILE SER GLU TYR ILE ASN ARG TRP PHE PHE VAL SEQRES 13 A 442 THR ILE THR ASN ASN LEU ASN ASN ALA LYS ILE TYR ILE SEQRES 14 A 442 ASN GLY LYS LEU GLU SER ASN THR ASP ILE LYS ASP ILE SEQRES 15 A 442 ARG GLU VAL ILE ALA ASN GLY GLU ILE ILE PHE LYS LEU SEQRES 16 A 442 ASP GLY ASP ILE ASP ARG THR GLN PHE ILE TRP MET LYS SEQRES 17 A 442 TYR PHE SER ILE PHE ASN THR GLU LEU SER GLN SER ASN SEQRES 18 A 442 ILE GLU GLU ARG TYR LYS ILE GLN SER TYR SER GLU TYR SEQRES 19 A 442 LEU LYS ASP PHE TRP GLY ASN PRO LEU MET TYR ASN LYS SEQRES 20 A 442 GLU TYR TYR MET PHE ASN ALA GLY ASN LYS ASN SER TYR SEQRES 21 A 442 ILE LYS LEU LYS LYS ASP SER PRO VAL GLY GLU ILE LEU SEQRES 22 A 442 THR ARG SER LYS TYR ASN GLN ASN SER LYS TYR ILE ASN SEQRES 23 A 442 TYR ARG ASP LEU TYR ILE GLY GLU LYS PHE ILE ILE ARG SEQRES 24 A 442 ARG LYS SER ASN SER GLN SER ILE ASN ASP ASP ILE VAL SEQRES 25 A 442 ARG LYS GLU ASP TYR ILE TYR LEU ASP PHE PHE ASN LEU SEQRES 26 A 442 ASN GLN GLU TRP ARG VAL TYR THR TYR LYS TYR PHE LYS SEQRES 27 A 442 LYS GLU GLU GLU LYS LEU PHE LEU ALA PRO ILE SER ASP SEQRES 28 A 442 SER ASP GLU PHE TYR ASN THR ILE GLN ILE LYS GLU TYR SEQRES 29 A 442 ASP GLU GLN PRO THR TYR SER CYS GLN LEU LEU PHE LYS SEQRES 30 A 442 LYS ASP GLU GLU SER THR ASP GLU ILE GLY LEU ILE GLY SEQRES 31 A 442 ILE HIS ARG PHE TYR GLU SER GLY TRP TRP PHE GLU GLU SEQRES 32 A 442 TYR LYS ASP TYR PHE CYS ILE SER LYS TRP TYR LEU LYS SEQRES 33 A 442 GLU VAL LYS ARG LYS PRO TYR ASN LEU LYS LEU GLY CYS SEQRES 34 A 442 ASN TRP GLN PHE ILE PRO LYS ASP GLU GLY TRP THR GLU SEQRES 1 S 21 GLY GLU GLY LYS GLU ASP ALA PHE SER LYS LEU LYS GLU SEQRES 2 S 21 LYS PHE MET ASN GLU LEU HIS LYS HET BGC B 1 12 HET GAL B 2 11 HET NGA B 3 14 HET GAL B 4 11 HET SIA B 5 20 HET SIA B 6 20 HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM NGA 2-ACETAMIDO-2-DEOXY-BETA-D-GALACTOPYRANOSE HETNAM SIA N-ACETYL-ALPHA-NEURAMINIC ACID HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN NGA N-ACETYL-BETA-D-GALACTOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NGA BETA-D-GALACTOSE; 2-ACETAMIDO-2-DEOXY-D-GALACTOSE; 2- HETSYN 3 NGA ACETAMIDO-2-DEOXY-GALACTOSE; N-ACETYL-D-GALACTOSAMINE HETSYN SIA N-ACETYLNEURAMINIC ACID; SIALIC ACID; ALPHA-SIALIC HETSYN 2 SIA ACID; O-SIALIC ACID FORMUL 3 BGC C6 H12 O6 FORMUL 3 GAL 2(C6 H12 O6) FORMUL 3 NGA C8 H15 N O6 FORMUL 3 SIA 2(C11 H19 N O9) FORMUL 4 HOH *85(H2 O) HELIX 1 AA1 LYS A 938 ASP A 940 5 3 HELIX 2 AA2 GLY A 941 ASN A 948 1 8 HELIX 3 AA3 SER A 1067 TYR A 1080 1 14 HELIX 4 AA4 TRP A 1262 VAL A 1267 1 6 HELIX 5 AA5 ASP S 38 HIS S 52 1 15 SHEET 1 AA1 5 LEU A 875 ASP A 877 0 SHEET 2 AA1 5 ILE A 864 TYR A 870 -1 N ARG A 869 O ILE A 876 SHEET 3 AA1 5 ILE A1054 PHE A1062 -1 O ILE A1061 N ILE A 865 SHEET 4 AA1 5 GLN A 898 LEU A 901 -1 N PHE A 899 O MET A1056 SHEET 5 AA1 5 GLU A 892 LEU A 893 -1 N GLU A 892 O LYS A 900 SHEET 1 AA2 7 LEU A 875 ASP A 877 0 SHEET 2 AA2 7 ILE A 864 TYR A 870 -1 N ARG A 869 O ILE A 876 SHEET 3 AA2 7 ILE A1054 PHE A1062 -1 O ILE A1061 N ILE A 865 SHEET 4 AA2 7 SER A 927 ARG A 933 -1 N SER A 929 O SER A1060 SHEET 5 AA2 7 PHE A1003 ASN A1009 -1 O VAL A1005 N PHE A 930 SHEET 6 AA2 7 ASN A1013 ILE A1018 -1 O TYR A1017 N THR A1006 SHEET 7 AA2 7 LYS A1021 ASP A1027 -1 O LYS A1021 N ILE A1018 SHEET 1 AA3 7 LYS A 884 VAL A 887 0 SHEET 2 AA3 7 ILE A 909 THR A 912 -1 O ARG A 910 N GLU A 886 SHEET 3 AA3 7 ILE A1040 ASP A1045 -1 O PHE A1042 N ILE A 909 SHEET 4 AA3 7 GLU A 949 LYS A 957 -1 N ASN A 954 O ILE A1041 SHEET 5 AA3 7 SER A 960 ARG A 967 -1 O ILE A 966 N TYR A 950 SHEET 6 AA3 7 ARG A 970 ILE A 976 -1 O ILE A 972 N SER A 965 SHEET 7 AA3 7 THR A 982 GLU A 988 -1 O VAL A 985 N TRP A 973 SHEET 1 AA4 2 TYR A1099 ASN A1102 0 SHEET 2 AA4 2 TRP A1280 ILE A1283 -1 O ILE A1283 N TYR A1099 SHEET 1 AA5 2 SER A1108 LEU A1112 0 SHEET 2 AA5 2 GLY A1119 THR A1123 -1 O GLU A1120 N LYS A1111 SHEET 1 AA6 4 PHE A1145 ARG A1149 0 SHEET 2 AA6 4 TYR A1166 ASN A1173 -1 O ASP A1170 N ILE A1146 SHEET 3 AA6 4 GLN A1176 TYR A1183 -1 O TRP A1178 N PHE A1171 SHEET 4 AA6 4 PHE A1194 PRO A1197 -1 O PHE A1194 N TYR A1181 SHEET 1 AA7 8 GLU A1190 LYS A1192 0 SHEET 2 AA7 8 GLU A1252 SER A1260 -1 O ILE A1259 N GLU A1191 SHEET 3 AA7 8 GLU A1234 SER A1246 -1 N GLY A1239 O CYS A1258 SHEET 4 AA7 8 GLN A1222 LYS A1226 -1 N LEU A1223 O ILE A1238 SHEET 5 AA7 8 THR A1207 LYS A1211 -1 N GLN A1209 O LEU A1224 SHEET 6 AA7 8 TYR A1166 ASN A1173 -1 N ILE A1167 O ILE A1208 SHEET 7 AA7 8 GLN A1176 TYR A1183 -1 O TRP A1178 N PHE A1171 SHEET 8 AA7 8 PHE A1204 TYR A1205 -1 O TYR A1205 N THR A1182 LINK O4 BGC B 1 C1 GAL B 2 1555 1555 1.44 LINK O4 GAL B 2 C1 NGA B 3 1555 1555 1.44 LINK O3 GAL B 2 C2 SIA B 6 1555 1555 1.45 LINK O3 NGA B 3 C1 GAL B 4 1555 1555 1.43 LINK O3 GAL B 4 C2 SIA B 5 1555 1555 1.45 CRYST1 50.344 78.491 149.103 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019863 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012740 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006707 0.00000